Related Experiment Video
Updated: Oct 4, 2025

Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021
Role of PemI in the Staphylococcus aureus PemIK toxin-antitoxin complex: PemI controls PemK by acting as a PemK loop
Do-Hee Kim1,2,3, Sung-Min Kang4, Sung-Min Baek3
1Jeju Research Institute of Pharmaceutical Sciences, College of Pharmacy, Jeju National University, Jeju 63243, Republic of Korea.
Abstract:
Staphylococcus aureus is a notorious and globally distributed pathogenic bacterium. New strategies to develop novel antibiotics based on intrinsic bacterial toxin-antitoxin (TA) systems have been recently reported. Because TA systems are present only in bacteria and not in humans, these distinctive systems are attractive targets for developing antibiotics with new modes of action. S. aureus PemIK is a type II TA system, comprising the toxin protein PemK and the labile antitoxin protein PemI. Here, we determined the crystal structures of both PemK and the PemIK complex, in which PemK is neutralized by PemI. Our biochemical approaches, including fluorescence quenching and polarization assays, identified Glu20, Arg25, Thr48, Thr49, and Arg84 of PemK as being important for RNase function. Our study indicates that the active site and RNA-binding residues of PemK are covered by PemI, leading to unique conformational changes in PemK accompanied by repositioning of the loop between β1 and β2. These changes can interfere with RNA binding by PemK. Overall, PemK adopts particular open and closed forms for precise neutralization by PemI. This structural and functional information on PemIK will contribute to the discovery and development of novel antibiotics in the form of peptides or small molecules inhibiting direct binding between PemI and PemK.
Insights
Novel antibiotics targeting bacterial toxin-antitoxin systems are emerging. This study reveals the structural basis of Staphylococcus aureus PemIK neutralization, crucial for developing new antibacterial agents.
Area of Science:
- Microbiology
- Structural Biology
- Drug Discovery
Background:
- Staphylococcus aureus is a significant global pathogen.
- Bacterial toxin-antitoxin (TA) systems offer novel antibiotic targets due to their absence in humans.
- The S. aureus PemIK system, a type II TA system, consists of toxin PemK and antitoxin PemI.
Purpose of the Study:
- To determine the crystal structures of PemK and the PemIK complex.
- To elucidate the mechanism of PemK neutralization by PemI.
- To identify key residues involved in PemK's RNase activity and inhibition.
Main Methods:
- X-ray crystallography to determine the structures of PemK and the PemIK complex.
- Biochemical assays, including fluorescence quenching and polarization, to assess protein interactions and function.
- Structure-based analysis to understand conformational changes and active site masking.
Main Results:
- The crystal structures of PemK and the PemIK complex were determined.
- PemI neutralizes PemK by covering its active site and RNA-binding residues.
- Specific residues (Glu20, Arg25, Thr48, Thr49, Arg84) in PemK are critical for its RNase function.
- PemI binding induces conformational changes in PemK, including repositioning of the β1-β2 loop, hindering RNA binding.
- PemK exhibits distinct open and closed conformations upon neutralization by PemI.
Conclusions:
- Structural and functional insights into the S. aureus PemIK system provide a foundation for novel antibiotic development.
- Targeting the interaction between PemI and PemK could lead to new antibacterial strategies.
- Inhibiting the PemI-PemK interaction may yield peptide or small molecule antibiotics against S. aureus.
More Related Videos
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Gene Regulation in Microbial Communities: Quorum Sensing
The Unfolded Protein Response

